Neuroscience News and Research

RSS

Astrazeneca, Taiwan's NRPB Launch Drug Discovery Collaboration

...

18 Oct 2013

Motor neurone disease neck collars: an interview with Dr Christopher J McDermott, Clinical Senior Lecturer, University of Sheffield

The majority of the current neck support collars for MND patients were designed for a different purpose. So, if you think about when people are involved in a road traffic accident, the paramedics arrive and put a collar on to immobilize the neck and protect the spine. A lot of the collars that we give to our patients with MND were actually designed for that purpose - to immobilize the necks of people involved in trauma… and patients don't want that.

18 Oct 2013

National survey reveals misconceptions about miscarriage

The majority of Americans inaccurately believe miscarriage is rare and misunderstand its causes, creating an often isolating and guilt-ridden experience for those who experience it. These are the findings in the first-ever national survey to assess attitudes and perceptions towards miscarriage, which was conducted by researchers at Montefiore Medical Center and the Albert Einstein College of Medicine of Yeshiva University.

18 Oct 2013

Gene variations in response to injury can impact clinical outcomes in TBI

Subtle variations in genes that regulate a person's inflammatory response to injury can impact clinical outcomes in TBI, according to a new study published in Journal of Neurotrauma.

18 Oct 2013

Researchers identify C. perfringens type B bacteria believed to trigger multiple sclerosis

A research team from Weill Cornell Medical College and The Rockefeller University has identified a bacterium it believes may trigger multiple sclerosis, a chronic, debilitating disorder that damages myelin forming cells in the brain and spinal cord.

18 Oct 2013

Study: Sleep allows brain to flush out damaging molecules linked with neurodegeneration

A good night's rest may literally clear the mind. Using mice, researchers showed for the first time that the space between brain cells may increase during sleep, allowing the brain to flush out toxins that build up during waking hours.

18 Oct 2013

Study shows how two miRNAs regulate FOXP2 gene implicated in speech, language impairments

A study led by Xiaoching Li, PhD, at the LSU Health Sciences Center New Orleans Neuroscience Center of Excellence, has shown for the first time how two tiny molecules regulate a gene implicated in speech and language impairments as well as autism disorders, and that social context of vocal behavior governs their function.

18 Oct 2013

Astrazeneca, Taiwan's NRPB Launch Drug Discovery Collaboration

...

17 Oct 2013

Proteins in CSF predict cognitive impairment before onset of disease

Johns Hopkins researchers say that by measuring levels of certain proteins in cerebrospinal fluid (CSF), they can predict when people will develop the cognitive impairment associated with Alzheimer's disease years before the first symptoms of memory loss appear.

17 Oct 2013

Elderly people with hardening of arteries are more likely to have beta-amyloid plaques in brain

Even for elderly people with no signs of dementia, those with hardening of the arteries are more likely to also have the beta-amyloid plaques in the brain that are a hallmark of Alzheimer's disease, according to a study published in the October 16, 2013, online issue of Neurology®, the medical journal of the American Academy of Neurology.

17 Oct 2013

Scientists uncover faulty brain mechanism that may underlie schizophrenia in humans

Working with mice genetically engineered to display symptoms of schizophrenia, neuroscientists at the RIKEN-MIT Center for Neural Circuit Genetics at the Picower Institute for Learning and Memory at MIT have uncovered a faulty brain mechanism that may underlie schizophrenia and other psychiatric disorders in humans.

17 Oct 2013

SAGE Therapeutics obtains $20M Series B financing from two investors

SAGE Therapeutics, a biopharmaceutical company developing novel medicines to treat central nervous system (CNS) diseases, today announced a $20 million Series B financing from investors ARCH Venture Partners and Third Rock Ventures, bringing the total raised to $57.8 million since launch in 2011.

16 Oct 2013

Seven promising scientists named 2013 NYSCF - Robertson Investigators

The New York Stem Cell Foundation today named seven of the most promising scientists as its 2013 NYSCF - Robertson Investigators.

16 Oct 2013

IRCM researchers identify new proteins crucial for hearing

A team of researchers led by Dr. Michel Cayouette at the IRCM made an important discovery, published online yesterday by the scientific journal Developmental Cell, that could better explain some inherited forms of hearing loss in humans. The Montr-al scientists identified a group of proteins crucial for shaping the cellular organ responsible for detecting sounds.

16 Oct 2013

Cerebral cortical development may influence recovery from childhood ADHD

Some people grow out of their childhood attention-deficit/hyperactivity disorder (ADHD) and some don't. In fact, around 50% of individuals diagnosed as children continue to suffer from ADHD as adults.

16 Oct 2013

Two institutions receive $25M grant from NIH to abet clinical and translational research

Albert Einstein College of Medicine of Yeshiva University and Montefiore Medical Center have received a $25 million grant from the National Institutes of Health (NIH) for the Harold and Muriel Block Institute for Clinical and Translational Research (ICTR) at Einstein and Montefiore.

16 Oct 2013

Elsevier journals currently offers 3D visualization services to authors and readers

Elsevier, a world-leading provider of scientific, technical and medical information products and services, and Kitware, a worldwide leader in developing advanced visualization technologies, today announced that Elsevier journals offer the opportunity to upload 3D datasets when submitting a paper for publication. This way, once published, readers can interactively explore 3D datasets next to the online article on ScienceDirect.

15 Oct 2013

Janssen seeks European marketing approval for combination of once-daily darunavir with cobicistat

Janssen-Cilag International NV, today announced it has submitted a Marketing Authorisation Application to the European Medicines Agency seeking approval for a once-daily single tablet fixed-dose antiretroviral combination product containing darunavir, a protease inhibitor developed by Janssen, with cobicistat, a pharmacokinetic enhancer or boosting agent, developed by Gilead Sciences, Inc. for use in combination with other human immunodeficiency virus medicines.

15 Oct 2013

High doses of ADHD drugs may be effective for people with amphetamine dependency

People with ADHD and dependency rarely respond as they should to ADHD drugs. A randomised study from Karolinska Institutet in Sweden now shows that it is possible to obtain the desired efficacy by administering the drug in higher doses.

15 Oct 2013

AstraZeneca announces Phase III study results of naloxegol in patients with non-cancer pain

AstraZeneca (NYSE: AZN) today announced the results of a Phase III long-term safety and tolerability study of the once-daily 25mg dose of naloxegol, in patients with non-cancer pain and opioid-induced constipation (OIC).

15 Oct 2013

Neuroscience News and Research

Astrazeneca, Taiwan's NRPB Launch Drug Discovery Collaboration

Motor neurone disease neck collars: an interview with Dr Christopher J McDermott, Clinical Senior Lecturer, University of Sheffield

National survey reveals misconceptions about miscarriage

Gene variations in response to injury can impact clinical outcomes in TBI

Researchers identify C. perfringens type B bacteria believed to trigger multiple sclerosis

Study: Sleep allows brain to flush out damaging molecules linked with neurodegeneration

Study shows how two miRNAs regulate FOXP2 gene implicated in speech, language impairments

Astrazeneca, Taiwan's NRPB Launch Drug Discovery Collaboration

Proteins in CSF predict cognitive impairment before onset of disease

Elderly people with hardening of arteries are more likely to have beta-amyloid plaques in brain

Scientists uncover faulty brain mechanism that may underlie schizophrenia in humans

SAGE Therapeutics obtains $20M Series B financing from two investors

Seven promising scientists named 2013 NYSCF - Robertson Investigators

IRCM researchers identify new proteins crucial for hearing

Cerebral cortical development may influence recovery from childhood ADHD

Two institutions receive $25M grant from NIH to abet clinical and translational research

Elsevier journals currently offers 3D visualization services to authors and readers

Janssen seeks European marketing approval for combination of once-daily darunavir with cobicistat

High doses of ADHD drugs may be effective for people with amphetamine dependency

AstraZeneca announces Phase III study results of naloxegol in patients with non-cancer pain

Event guide: 8th Neuroimmunology Drug Development Summit 2026 eBook

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News